Formycon AG

XTRA:FYB Stock Report

Market Cap: €350.1m

Formycon Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Stefan Glombitza

Chief executive officer

€612.3k

Total compensation

CEO salary percentage57.16%
CEO tenure9.5yrs
CEO ownershipn/a
Management average tenure3.8yrs
Board average tenure1.8yrs

Recent management updates

Recent updates

Regulatory Tailwinds And Biosimilar Royalties Will Slowly Overcome Concentrated Pipeline Risks

Catalysts About Formycon Formycon develops and commercializes biosimilar medicines in collaboration with partners across global markets. What are the underlying business or industry changes driving this perspective?

Regulatory Tailwinds And Biosimilar Pipeline Will Reshape Long Term Earnings Power

Catalysts About Formycon Formycon develops and commercializes biosimilar medicines, focusing on high-value biologics in ophthalmology, immunology and oncology. What are the underlying business or industry changes driving this perspective?
User avatar

Expected Launches Of Stelara And Keytruda Biosimilars Will Strengthen Future Pipeline

The launch of biosimilars and strategic focus on high-growth areas indicate strong future revenue and earnings potential for Formycon.

A Look At The Fair Value Of Formycon AG (ETR:FYB)

Jul 20
A Look At The Fair Value Of Formycon AG (ETR:FYB)

Formycon AG's (ETR:FYB) Prospects Need A Boost To Lift Shares

May 29
Formycon AG's (ETR:FYB) Prospects Need A Boost To Lift Shares

We Believe Formycon's (ETR:FYB) Earnings Are A Poor Guide For Its Profitability

May 03
We Believe Formycon's (ETR:FYB) Earnings Are A Poor Guide For Its Profitability

Some Confidence Is Lacking In Formycon AG's (ETR:FYB) P/S

Jan 19
Some Confidence Is Lacking In Formycon AG's (ETR:FYB) P/S

We Think Formycon (ETR:FYB) Needs To Drive Business Growth Carefully

Dec 23
We Think Formycon (ETR:FYB) Needs To Drive Business Growth Carefully

Formycon AG's (ETR:FYB) Share Price Not Quite Adding Up

Sep 26
Formycon AG's (ETR:FYB) Share Price Not Quite Adding Up

We Think You Should Be Aware Of Some Concerning Factors In Formycon's (ETR:FYB) Earnings

Nov 05
We Think You Should Be Aware Of Some Concerning Factors In Formycon's (ETR:FYB) Earnings

We're Hopeful That Formycon (ETR:FYB) Will Use Its Cash Wisely

Sep 04
We're Hopeful That Formycon (ETR:FYB) Will Use Its Cash Wisely

Analysts Just Published A Bright New Outlook For Formycon AG's (ETR:FYB)

Jul 13
Analysts Just Published A Bright New Outlook For Formycon AG's (ETR:FYB)

Bearish: Analysts Just Cut Their Formycon AG (ETR:FYB) Revenue and EPS estimates

Jun 02
Bearish: Analysts Just Cut Their Formycon AG (ETR:FYB) Revenue and EPS estimates

Here's Why We're Not Too Worried About Formycon's (ETR:FYB) Cash Burn Situation

May 23
Here's Why We're Not Too Worried About Formycon's (ETR:FYB) Cash Burn Situation

CEO Compensation Analysis

How has Stefan Glombitza's remuneration changed compared to Formycon's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-€165m

Jun 30 2025n/an/a

-€170m

Mar 31 2025n/an/a

-€148m

Dec 31 2024€612k€350k

-€126m

Sep 30 2024n/an/a

€16m

Jun 30 2024n/an/a

€64m

Mar 31 2024n/an/a

€70m

Dec 31 2023€582k€350k

€76m

Sep 30 2023n/an/a

€17m

Jun 30 2023n/an/a

-€42m

Mar 31 2023n/an/a

-€3m

Dec 31 2022€2mn/a

€36m

Sep 30 2022n/an/a

€57m

Jun 30 2022n/an/a

€77m

Mar 31 2022n/an/a

€32m

Dec 31 2021€617kn/a

-€13m

Compensation vs Market: Stefan's total compensation ($USD720.61K) is below average for companies of similar size in the German market ($USD1.06M).

Compensation vs Earnings: Stefan's compensation has increased whilst the company is unprofitable.

CEO

Stefan Glombitza (60 yo)

9.5yrs
Tenure
€612,300
Compensation

Dr. Stefan Glombitza has been Member of Executive Board at Formycon AG since October 1, 2016 and its Chief Executive Officer since July 01, 2022. Dr. Glombitza serves as Chief Operating Officer of Formycon...

Leadership Team

NamePositionTenureCompensationOwnership
Stefan Glombitza
CEO, COO & Chair of the Executive Board9.5yrs€612.30kno data
Nicolas Combe
Co-Founderno datano datano data
Enno Spillner
CFO & Member of the Executive Board3yrs€560.90kno data
Andreas Seidl
Chief Scientific Officer & Member of the Executive Board3.8yrs€339.50kno data
Nicola Mikulcik
Chief Business Officer & Member of the Executive Board3.8yrs€393.80kno data
Friedrich-Wilhelm Steinweg
Co-Founderno datano datano data
Sabrina Muller
Director of Investor Relations & Corporate Communicationsno datano datano data
3.8yrs
Average Tenure
55.5yo
Average Age

Experienced Management: FYB's management team is considered experienced (3.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Colin Bond
Independent Deputy Chairman of the Supervisory Board1.5yrs€22.50kno data
Nicholas Haggar
Independent Member of the Supervisory Board1.8yrs€35.80kno data
Klaus Rohrig
Member of the Supervisory Board5.3yrs€39.00kno data
Wolfgang Essler
Chairman of the Supervisory Board2.8yrs€67.80kno data
Bodo Coldewey
Independent Member of the Supervisory Board1.8yrs€29.30kno data
Graham Dixon
Member of the Supervisory Boardless than a yearno datano data
1.8yrs
Average Tenure
54yo
Average Age

Experienced Board: FYB's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/20 14:59
End of Day Share Price 2026/04/17 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Formycon AG is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gerhard OrgonasBerenberg
Benjamin ThielmannBerenberg
Simon ScholesFirst Berlin Equity Research GmbH